α-methyl-1,3-benzodioxole-5-propionaldehyde

CAS1205-17-0
EC214-881-6

List details

Basic info

Status Opinion Adopted
Submitter Denmark
Submitter email mst@mst.dk
Regulatory programme
  • Chemical registered under REACH
Further substance information All identified IUPAC names: (1,3-benzodioxol-5-yl)-2-methyl propanal (2R)-3-(1,3-benzodioxol-5-yl)-2-methylpropanal 2-Methyl-3-(3,4 methylendioxylphenyl)-propanal 2-methyl-3-(3,4-methylene dioxyphenyl)-propanal 2-Methyl-3-(3,4-methylenedioxyphenyl)propionaldehyde 3-(1,3-Benzodioxol-5-yl)-2-methylpropanal 3-(2H-1,3-benzodioxol-5-yl)-2-methylpropanal 3-(3,4-methylenedioxyphenyl)-2-2-methylpropanal 5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione alpha-Methyl-1,3-benzodioxole-5-propionaldehyde alpha-Methyl-3,4-methylene-dioxyhydrocinnamicaldehyde

Classification

Proposed harmonised classification by the dossier submitter
  • Skin Sens. 1B, H317
Hazard classes open for commenting Skin sensitisation

Intention timeline

Date of intention 2020-08-11
Expected date of submission 2020-12-31
Submitted for accordance check 2020-10-05
Final submission date 2021-06-01
Start of consultation 2021-08-09
Deadline for commenting 2021-10-08
Date of opinion 2022-03-18
Legal deadline for opinion adoption 2022-12-01

Documents

CLH report
Annexes to the CLH Report
Comments received
RAC opinion
Background document

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

This version
June 24, 2022
  • Background document: https://echa.europa.eu/documents/10162/072b617c-70b2-68c8-c841-8f194c2f0d3b
  • Comments received: https://echa.europa.eu/documents/10162/ab4928c1-2783-aecc-11d5-acb8151d0c6e
  • RAC opinion: https://echa.europa.eu/documents/10162/e8c418c1-4203-e9f0-5bdb-3796ebb4d2a1
June 6, 2022
  • Comments received: https://echa.europa.eu/documents/10162/b0b3a845-9a78-4743-532e-4bcb1bbf2ae8
April 26, 2022
  • Date of opinion: 2022-03-18
  • Status: Opinion DevelopmentOpinion Adopted
Oct. 27, 2021
  • Comments received: https://echa.europa.eu/documents/10162/b0b3a845-9a78-4743-532e-4bcb1bbf2ae8
Oct. 19, 2021
  • Status: ConsultationOpinion Development
Oct. 8, 2021
  • Annexes to the CLH Report: https://echa.europa.eu/documents/10162/9fa4e640-fcb9-e0f6-32a0-f6a351f6cfe5
  • CLH report: https://echa.europa.eu/documents/10162/a26f3630-4c62-394f-2171-447c862c14bd
  • Deadline for commenting: 2021-10-08
  • Final submission date: 2021-06-01
  • Hazard classes open for commenting: Skin sensitisation
  • Legal deadline for opinion adoption: 2022-12-01
  • Status: SubmittedConsultation
  • Start of consultation: 2021-08-09
April 9, 2021
  • Name: 3-(1,3-benzodioxol-5-yl)-2-methylpropanalα-methyl-1,3-benzodioxole-5-propionaldehyde
March 31, 2021
  • Name: α-methyl-1,3-benzodioxole-5-propionaldehyde3-(1,3-benzodioxol-5-yl)-2-methylpropanal
Add the related substance to your watchlist to monitor this regulatory record.